IE39831B1 - Phthalazone compounds - Google Patents

Phthalazone compounds

Info

Publication number
IE39831B1
IE39831B1 IE1825/74A IE182574A IE39831B1 IE 39831 B1 IE39831 B1 IE 39831B1 IE 1825/74 A IE1825/74 A IE 1825/74A IE 182574 A IE182574 A IE 182574A IE 39831 B1 IE39831 B1 IE 39831B1
Authority
IE
Ireland
Prior art keywords
compound
group
formula
tha
methyl
Prior art date
Application number
IE1825/74A
Other languages
English (en)
Other versions
IE39831L (en
Original Assignee
Inoue Michiro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12126073A external-priority patent/JPS5732065B2/ja
Priority claimed from JP12175773A external-priority patent/JPS5724786B2/ja
Application filed by Inoue Michiro filed Critical Inoue Michiro
Publication of IE39831L publication Critical patent/IE39831L/en
Publication of IE39831B1 publication Critical patent/IE39831B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE1825/74A 1973-10-30 1974-09-03 Phthalazone compounds IE39831B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12126073A JPS5732065B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-10-30 1973-10-30
JP12175773A JPS5724786B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-10-31 1973-10-31

Publications (2)

Publication Number Publication Date
IE39831L IE39831L (en) 1975-04-30
IE39831B1 true IE39831B1 (en) 1979-01-03

Family

ID=26458679

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1825/74A IE39831B1 (en) 1973-10-30 1974-09-03 Phthalazone compounds

Country Status (20)

Country Link
US (1) US3963716A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR205004A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1029377A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (2) CH610892A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD119231A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2451417C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK134345B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES431454A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI59402C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2248841B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1459606A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU168797B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE39831B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL45675A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN139552B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU71191A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7414186A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH10519A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE412389B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU289774A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120960A (en) * 1973-10-31 1978-10-17 The Boots Company Limited Therapeutic agents
NL7702763A (nl) * 1976-03-18 1977-09-20 Takio Shimamoto En Masayuki Is Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten.
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
US4464532A (en) * 1979-07-31 1984-08-07 Nippon Kayaku Kabushiki Kaisha Intermediates of 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone
JPS5668609A (en) * 1979-11-07 1981-06-09 Nippon Kayaku Co Ltd Phthalazinol preparation
JPS58116471A (ja) * 1981-12-29 1983-07-11 Nippon Kayaku Co Ltd 4−ヒドロキシメチル−1−フタラゾンエステル誘導体およびその塩
GB2127805A (en) * 1982-09-13 1984-04-18 Showa Denko Kk Phthalazones
US4861778A (en) * 1986-06-16 1989-08-29 Research Corporation 2,3-dihydrophthalazine-1,4-diones
ATE117553T1 (de) * 1988-08-19 1995-02-15 Warner Lambert Co Substituierte dihydroisochinolinone und verwandte verbindungen als verstärker der letalen effekte von bestrahlung und bestimmten chemotherapeutika; ausgewählte verbindungen, analoga und verfahren.
US5177075A (en) * 1988-08-19 1993-01-05 Warner-Lambert Company Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
DE4333761A1 (de) * 1993-10-04 1995-04-06 Luitpold Pharma Gmbh Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel
RU2169139C1 (ru) * 2000-08-02 2001-06-20 Закрытое акционерное общество "Центр современной медицины "Медикор" Способ получения щелочных и щелочноземельных солей 5-амино-2,3-дигидро-1,4-фталазиндиона
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
TWI513462B (zh) 2009-11-13 2015-12-21 Toray Industries 糖尿病之治療或預防藥
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
HK1218629A1 (zh) 2013-02-25 2017-03-03 Bausch Health Ireland Limited 用於结肠清洁的鸟苷酸环化酶受体激动剂
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
MX375926B (es) 2013-08-09 2025-03-07 Ardelyx Inc Compuestos y metodos para inhibir el transporte de fosfato.
EP3972599A1 (en) 2019-05-21 2022-03-30 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5116430B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1971-08-05 1976-05-24
US3870792A (en) * 1972-07-24 1975-03-11 Michiro Inoue Certain dihydrophthalizines for treating hemorrhage and thrombosis

Also Published As

Publication number Publication date
IN139552B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-07-03
AU7295474A (en) 1976-03-11
GB1459606A (en) 1976-12-22
ES431454A1 (es) 1976-10-16
CH610892A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-05-15
DK134345C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-03-21
IL45675A (en) 1978-10-31
NL7414186A (nl) 1975-05-02
DK134345B (da) 1976-10-25
SE412389B (sv) 1980-03-03
DE2451417A1 (de) 1975-05-07
FI59402B (fi) 1981-04-30
YU289774A (en) 1983-01-21
HU168797B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-07-28
LU71191A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-04-17
CH611282A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-05-31
SE7413530L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-05-02
IE39831L (en) 1975-04-30
FR2248841B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-07-28
US3963716A (en) 1976-06-15
FI59402C (fi) 1981-08-10
DK561874A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-07-07
DD119231A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-04-12
PH10519A (en) 1977-05-26
IL45675A0 (en) 1974-11-29
DE2451417C3 (de) 1981-01-29
CA1029377A (en) 1978-04-11
DE2451417B2 (de) 1980-05-14
AR205004A1 (es) 1976-03-31
FI315774A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-05-01
FR2248841A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-05-23

Similar Documents

Publication Publication Date Title
IE39831B1 (en) Phthalazone compounds
KR880002298B1 (ko) 술포네이트 유도체의 제조법
McEvoy et al. 6-(Substituted phenyl)-5-substituted-4, 5-dihydro-3 (2H)-pyridazinones. Antihypertensive agents
NO744183L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU178302B (en) Process for producing n-amidino-3,5-diamino-6-substituted-2-piperazine-carboxamides
KR100878739B1 (ko) 발기부전 치료를 위한 신규한 화합물
JPH04202127A (ja) インターロイキン―1産生抑制剤
US3966783A (en) Compounds
HU185329B (en) Process for preparing quinolone derivatives and pharmaceutical compositions containing such compounds
US5294718A (en) Piperidino-3,4-dihydrocarbostyril compounds
EP0683159A1 (de) Substituierte Furoxane
JPH01258667A (ja) 高脂血症治療用組成物
SU982544A3 (ru) Способ получени 5,8-дигидро-5-этил-8-оксофуро (3,2в)-1,8-нафтиридин-7-карбоновой кислоты или ее соли
KR790001259B1 (ko) 1-프탈라존 유도체의 제조법
JPS6317068B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0049144B1 (en) 5-fluoro uracil derivatives
EP0982308B1 (fr) Dérivés de 8H-(2,3-b)-pyrrolizine-8-one, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US4282245A (en) Dibenzothiepin derivatives and a process for producing the same
US3201475A (en) Bisglyoxalyldiphenyl derivatives
JPH04120076A (ja) ジチオールイリデン誘導体
PL100122B1 (pl) Sposob wytwarzania nowych pochodnych ftalazonu-1
LU85690A1 (fr) Nouveaux derives de a pyrazolo (1,5-a) pyridine,leur preparation et les compositions therapeutiques qui les contiennent
JPH0670013B2 (ja) 3‐ニトロ‐ジヒドロピリジン類
US4732909A (en) 3-(3-halophenyl-3,4-diazatetracyclo-[6.3.1.16,10.01,5 ]tridec-4-en-2-one compounds and use thereof to treat hypoxia
PL117861B1 (en) Process for preparing novel derivatives of phthalaz-1-one